deltatrials
Terminated OBSERVATIONAL NCT02654340

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (TuScCom)

Biomarkers for Tuberous Sclerosis Complex: An International Multicenter Observational Longitudinal Protocol

Sponsor: CENTOGENE GmbH Rostock

Updated 24 times since 2017 Last updated: Feb 8, 2023 Started: Aug 1, 2018 Primary completion: Dec 30, 2022 Completion: Dec 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study no longer pursued.

This observational or N/A phase trial investigates Cardiac Rhabdomyoma and Cortical Dysplasia and is currently terminated or withdrawn. CENTOGENE GmbH Rostock leads this study, which shows 24 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2019 · 7 months · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Apr 2020 · 10 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Aug 2020 · 3 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Mar 2023 · 11 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated

  4. Mar 2023 — Jul 2024 [monthly]

    Terminated

    Status: Active Not RecruitingTerminated

  5. Apr 2022 — Mar 2023 [monthly]

    Active Not Recruiting

Show 19 earlier versions
  1. Dec 2021 — Apr 2022 [monthly]

    Active Not Recruiting

  2. Jun 2021 — Dec 2021 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  3. May 2021 — Jun 2021 [monthly]

    Recruiting

  4. Apr 2021 — May 2021 [monthly]

    Recruiting

  5. Jan 2021 — Apr 2021 [monthly]

    Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  7. Aug 2020 — Nov 2020 [monthly]

    Recruiting

  8. May 2020 — Aug 2020 [monthly]

    Recruiting

  9. Apr 2020 — May 2020 [monthly]

    Recruiting

  10. Jun 2019 — Apr 2020 [monthly]

    Recruiting

  11. May 2019 — Jun 2019 [monthly]

    Recruiting

  12. Apr 2019 — May 2019 [monthly]

    Recruiting

    Status: Not Yet RecruitingRecruiting

  13. Mar 2019 — Apr 2019 [monthly]

    Not Yet Recruiting

    Status: RecruitingNot Yet Recruiting

  14. Aug 2018 — Mar 2019 [monthly]

    Recruiting

  15. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  16. May 2018 — Jun 2018 [monthly]

    Recruiting

  17. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  18. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  19. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CENTOGENE GmbH Rostock
Data source: CENTOGENE GmbH Rostock

For direct contact, visit the study record on ClinicalTrials.gov .